IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE

Szekanecz, Zoltán; Sebestyén, Enikő; Major, Nóra; Bodoki, Levente; Makai, Attila; Balogh, Ingrid; Tóth, Gábor; Orosz, Zsuzsanna; Árkosy, Péter; Vaskó, Attila; Hodosi, Katalin; Szekanecz, Éva

doi:10.33004/reumatizam-supp-70-1-10

Reumatizam, Vol. 70 No. Supp 1, 2023.

Meeting abstract

https://doi.org/10.33004/reumatizam-supp-70-1-10

IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE

Zoltán Szekanecz ; 1University of Debrecen, Faculty of Medicine, Departments of Rheumatology, Debrecen, Hungary
Enikő Sebestyén
Nóra Major
Levente Bodoki
Attila Makai
Ingrid Balogh
Gábor Tóth
Zsuzsanna Orosz
Péter Árkosy
Attila Vaskó
Katalin Hodosi
Éva Szekanecz

Full text: english pdf 982 Kb

page 10-10

downloads: 112

cite

APA 6th Edition

Szekanecz, Z., Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., ... Szekanecz, É. (2023). IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE. Reumatizam, 70 (Supp 1), 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

MLA 8th Edition

Szekanecz, Zoltán, et al. "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE." Reumatizam, vol. 70, no. Supp 1, 2023, pp. 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10. Accessed 24 Dec. 2024.

Chicago 17th Edition

Szekanecz, Zoltán, Enikő Sebestyén, Nóra Major, Levente Bodoki, Attila Makai, Ingrid Balogh, Gábor Tóth, et al. "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE." Reumatizam 70, no. Supp 1 (2023): 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

Harvard

Szekanecz, Z., et al. (2023). 'IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE', Reumatizam, 70(Supp 1), pp. 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

Vancouver

Szekanecz Z, Sebestyén E, Major N, Bodoki L, Makai A, Balogh I, et al. IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE. Reumatizam [Internet]. 2023 [cited 2024 December 24];70(Supp 1):10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

IEEE

Z. Szekanecz, et al., "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE", Reumatizam, vol.70, no. Supp 1, pp. 10-10, 2023. [Online]. https://doi.org/10.33004/reumatizam-supp-70-1-10

Abstract

Keywords

checkpoint inhibitors, immune-related, adverse events

Hrčak ID:

309335

URI

https://hrcak.srce.hr/309335

Publication date:

16.10.2023.

Visits: 295 *

Login and registration

Reumatizam, Vol. 70 No. Supp 1, 2023.

Abstract

Keywords

Hrčak ID:

URI

Publication date: